Griffin: Accessing functional antibodies from serum without B cells
Griffin is a platform for sequencing polyclonal antibodies using mass spectrometry. Since 2009, Abterra Biosciences founders and employees have been developing novel methods for sequencing antibody proteins directly. Our monoclonal antibody sequencing service, Valens, has been used to successfully sequence hundreds of antibodies without the need for B cells. Now, with Griffin, we can sequencing complex mixes of antibodies directly from patient serum, or from immunized animals.
Watch our CEO, Dr. Natalie Castellana’s presentation on Unlocking the Serum Antibody Repertoire: Accessing Functional Antibodies without B Cells to learn how Griffin works.
Click below to watch the presentation.
Related Posts
Polyclonal Antibody Sequencing Methods
Polyclonal Antibody Sequencing Methods Polyclonal antibody sequencing is a powerful tool for understanding the humoral immune response.1 Two primary approaches exist: Proteogenomic Polyclonal Antibody Sequencing and De Novo Polyclonal Antibody Sequencing. This guide...
Antibody Clonality Assessment
Antibody Clonality Background The serological compartment is simple to access and contains a multitude of proteins, a large fraction of which are circulating antibodies. At Abterra Bio, we developed Alicanto which utilizes B cells from a variety of sources, including...
Unlocking the Secrets of SARS-CoV-2 Immunity: A Deep Dive into Serum Antibodies and B Cell Repertoires
Project Summary We're excited to share our latest findings on the complex interplay between serum antibodies and B cell repertoires in individuals with SARS-CoV-2 immunity. Our study offers new insights into the development of high-affinity antibodies against emerging...
Get In Touch